Literature DB >> 1332867

Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung.

M Kagoshima1, T Kinoshita, K Matsumoto, T Nakamura.   

Abstract

Hepatocyte growth factor (HGF) is a mesenchymal-derived factor which induces mitosis, cell movement and morphogenesis of tissue-like structure. We analyzed changes in HGF mRNA and its receptor, the c-met proto-oncogene product, in the liver, kidney and lung during late fetal and postnatal development in rats. In the liver, the HGF-mRNA level was very low during late gestation and in neonates, it increased remarkably and reached a maximum two weeks postnatally, to be followed by a decrease to 33% of the maximum. HGF mRNA in the kidney and lung was either undetectable or very low during late gestation and the neonatal period and increased markedly to reach a maximum, respectively, 3-4 weeks postnatally. HGF-mRNA level in the adult rat lung was fivefold higher than that in the liver and kidney. The number of HGF receptors on plasma membranes of these tissues was low in neonates but there was a rapid increase after birth and a maximum was reached within three weeks. The number of HGF receptors/ng plasma membrane protein at the maximal level was highest in the liver and lowest in the lung. c-met/HGF-receptor mRNA in the liver was also low during late-gestation or in early neonatal periods and increased postnatally. Since HGF-mRNA and HGF-receptor levels changed differently in liver, kidney and lung, the expression of HGF and its receptor may be independently regulated in each organ. However, in these organs, HGF mRNA and the HGF receptor increased within a few weeks of birth, HGF may play roles in organ growth, organ maturation and the maintenance of tissue homeostasis during the postnatal period, presumably through its potential to act as mitogen, motogen and morphogen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332867     DOI: 10.1111/j.1432-1033.1992.tb17431.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

2.  C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.

Authors:  S Lin; D Rusciano; P Lorenzoni; G Hartmann; W Birchmeier; S Giordano; P Comoglio; M M Burger
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

3.  Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization.

Authors:  K Yamaguchi; M A Nalesnik; G K Michalopoulos
Journal:  Urol Res       Date:  1996

4.  Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.

Authors:  Dipak Panigrahy; Irit Adini; Roni Mamluk; Nicholas Levonyak; Christiane J Bruns; Patricia A D'Amore; Michael Klagsbrun; Diane R Bielenberg
Journal:  Pathology       Date:  2014-08       Impact factor: 5.306

5.  Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism.

Authors:  Ognoon Mungunsukh; Regina M Day
Journal:  Mol Biol Cell       Date:  2013-05-08       Impact factor: 4.138

Review 6.  Met in urological cancers.

Authors:  Yasuyoshi Miyata; Akihiro Asai; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Yasushi Mochizuki; Hideki Sakai
Journal:  Cancers (Basel)       Date:  2014-12-16       Impact factor: 6.639

7.  Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.

Authors:  E Ichimura; A Maeshima; T Nakajima; T Nakamura
Journal:  Jpn J Cancer Res       Date:  1996-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.